These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11689562)

  • 1. The mode of action of heparan and dermatan sulfates in the regulation of hepatocyte growth factor/scatter factor.
    Lyon M; Deakin JA; Gallagher JT
    J Biol Chem; 2002 Jan; 277(2):1040-6. PubMed ID: 11689562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interactions of hepatocyte growth factor/scatter factor and its NK1 and NK2 variants with glycosaminoglycans using a modified gel mobility shift assay. Elucidation of the minimal size of binding and activatory oligosaccharides.
    Lyon M; Deakin JA; Lietha D; Gherardi E; Gallagher JT
    J Biol Chem; 2004 Oct; 279(42):43560-7. PubMed ID: 15292253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and Characterization of a Chinese Hamster Ovary Heparan Sulfate Cell Mutant Defective in Both Met Receptor Binding and Hepatocyte Growth Factor NK1/Met Signaling.
    Cao T; Pan J; Li X; He Y; Jiang Y; Chang Y; Zhang Q; Lan Y; Wang H; Jiao W; Tian Z; Zhang L
    Cell Physiol Biochem; 2018; 48(4):1480-1491. PubMed ID: 30107380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The binding properties of minimal oligosaccharides reveal a common heparan sulfate/dermatan sulfate-binding site in hepatocyte growth factor/scatter factor that can accommodate a wide variety of sulfation patterns.
    Deakin JA; Blaum BS; Gallagher JT; Uhrín D; Lyon M
    J Biol Chem; 2009 Mar; 284(10):6311-21. PubMed ID: 19114710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the structure/function of hepatocyte growth factor/scatter factor from studies with individual domains.
    Holmes O; Pillozzi S; Deakin JA; Carafoli F; Kemp L; Butler PJ; Lyon M; Gherardi E
    J Mol Biol; 2007 Mar; 367(2):395-408. PubMed ID: 17258232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor/scatter factor and its interaction with heparan sulphate and dermatan sulphate.
    Catlow K; Deakin JA; Delehedde M; Fernig DG; Gallagher JT; Pavão MS; Lyon M
    Biochem Soc Trans; 2003 Apr; 31(2):352-3. PubMed ID: 12653636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling.
    Sakata H; Stahl SJ; Taylor WG; Rosenberg JM; Sakaguchi K; Wingfield PT; Rubin JS
    J Biol Chem; 1997 Apr; 272(14):9457-63. PubMed ID: 9083085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling.
    Rubin JS; Day RM; Breckenridge D; Atabey N; Taylor WG; Stahl SJ; Wingfield PT; Kaufman JD; Schwall R; Bottaro DP
    J Biol Chem; 2001 Aug; 276(35):32977-83. PubMed ID: 11435444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met.
    van der Voort R; Taher TE; Wielenga VJ; Spaargaren M; Prevo R; Smit L; David G; Hartmann G; Gherardi E; Pals ST
    J Biol Chem; 1999 Mar; 274(10):6499-506. PubMed ID: 10037743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity.
    Zioncheck TF; Richardson L; Liu J; Chang L; King KL; Bennett GL; Fügedi P; Chamow SM; Schwall RH; Stack RJ
    J Biol Chem; 1995 Jul; 270(28):16871-8. PubMed ID: 7622503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling.
    Kirchhofer D; Yao X; Peek M; Eigenbrot C; Lipari MT; Billeci KL; Maun HR; Moran P; Santell L; Wiesmann C; Lazarus RA
    J Biol Chem; 2004 Sep; 279(38):39915-24. PubMed ID: 15218027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor/scatter factor: a heparan sulphate-binding pleiotropic growth factor.
    Lyon M; Gallagher JT
    Biochem Soc Trans; 1994 May; 22(2):365-70. PubMed ID: 7958326
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatocyte growth factor/scatter factor binds to small heparin-derived oligosaccharides and stimulates the proliferation of human HaCaT keratinocytes.
    Delehedde M; Lyon M; Vidyasagar R; McDonnell TJ; Fernig DG
    J Biol Chem; 2002 Apr; 277(14):12456-62. PubMed ID: 11799124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin amplifies platelet-derived growth factor (PDGF)- BB-induced PDGF alpha -receptor but not PDGF beta -receptor tyrosine phosphorylation in heparan sulfate-deficient cells. Effects on signal transduction and biological responses.
    Rolny C; Spillmann D; Lindahl U; Claesson-Welsh L
    J Biol Chem; 2002 May; 277(22):19315-21. PubMed ID: 11912193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
    Krufka A; Guimond S; Rapraeger AC
    Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of hepatocyte growth factor/scatter factor by cell surface proteoglycans and free glycosaminoglycan chains.
    Deakin JA; Lyon M
    J Cell Sci; 1999 Jun; 112 ( Pt 12)():1999-2009. PubMed ID: 10341217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor.
    Lietha D; Chirgadze DY; Mulloy B; Blundell TL; Gherardi E
    EMBO J; 2001 Oct; 20(20):5543-55. PubMed ID: 11597998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel heparin/heparan sulfate mimics as inhibitors of HGF/SF-induced MET activation.
    Raiber EA; Wilkinson JA; Manetti F; Botta M; Deakin J; Gallagher J; Lyon M; Ducki SW
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6321-5. PubMed ID: 17870532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors.
    Kemp LE; Mulloy B; Gherardi E
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):414-7. PubMed ID: 16709175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density.
    Catlow KR; Deakin JA; Wei Z; Delehedde M; Fernig DG; Gherardi E; Gallagher JT; Pavão MS; Lyon M
    J Biol Chem; 2008 Feb; 283(9):5235-48. PubMed ID: 18156180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.